Figure 1 . Circulating CXCL16 concentrations in the patients
with sepsis were increased. (A) Soluble levels of serum CXCL16 in 55
septic patients and 30 healthy controls. (B) The dynamics of soluble
CXCL16 levels in the serum of patients with sepsis. (C) Soluble CXCL16
levels in the serum collected from patients with septic shock and
patients without shock on day of ICU admission. (D) Soluble CXCL16
levels in the serum collected from septic survivors and nonsurvivors.
Nonparametric Mann–Whitney U test or Kruskal-Wallis test
followed by Dunn’s multiple comparisons post test was performed to
analyze results between groups. Horizontal bars represent median values,
and dots represent individual participants.